Camidge, D R : rechercher sur Z-Library

Campagne de collecte 15 septembre 2024 – 1 octobre 2024 C'est quoi, la collecte de fonds?

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Campagne de collecte 15 septembre 2024 – 1 octobre 2024

Z-Library est une des plus grandes bibliothèques en ligne dans le monde, avec le stockage de plus de 17,000,000 livres et plus de 84,837,000 articles. Nous encourageons l'accès libre de chacun à la littérature. Aujourd'hui (15 septembre 2024) nous faisons un appel de fonds à tous ceux qui veulent contribuer encore plus au soutien et au développement de notre projet.

Les téléchargements SANS LIMITE sont aussi (au cours de 31 jours après la date de don) disponibles pour TOUS les utilisateurs qui soient en mesure de soutenir le projet pendant la période de collecte de fonds jusqu'au 1 octobre 2024.

C'est quoi, la collecte de fonds?En savoir plus

Livres
Articles (358)
Les plus populaires
Liste
- Liste
- Tableau

1

Frankenstein: or, The Modern Prometheus

Journal:

Année:

2007

Langue:

english

Fichier:

PDF, 315 KB

english, 2007

2

Repotrectinib (TPX-0005) is a next generation ROS1/TRK/ALK inhibitor that potently inhibits ROS1/TRK/ALK solvent front mutations

Drilon, Alexander, Ou, Sai-Hong I., Cho, Byoung Chul, Kim, Dong-Wan, Lee, Jeeyun, Lin, Jessica J., Zhu, Viola W, Ahn, Myung-Ju, Camidge, D. Ross, Nguyen, Judy, Zhai, Dayong, Deng, Wei, Huang, Zhongdon

Journal:

Cancer Discovery

Année:

2018

Langue:

english

Fichier:

PDF, 5.57 MB

english, 2018

3

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

Gomez, Daniel R., Tang, Chad, Zhang, Jianjun, Blumenschein, George R., Hernandez, Mike, Lee, J. Jack, Ye, Rong, Palma, David A., Louie, Alexander V., Camidge, D. Ross, Doebele, Robert C., Skoulidis, F

Journal:

Journal of Clinical Oncology

Année:

2019

Langue:

english

Fichier:

PDF, 709 KB

english, 2019

4

Ceritinib in ALK -Rearranged Non–Small-Cell Lung Cancer

Shaw, Alice T., Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Camidge, D. Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, B

Journal:

New England Journal of Medicine

Année:

2014

Langue:

english

Fichier:

PDF, 679 KB

english, 2014

5

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

Kwak, Eunice L., Bang, Yung-Jue, Camidge, D. Ross, Shaw, Alice T., Solomon, Benjamin, Maki, Robert G., Ou, Sai-Hong I., Dezube, Bruce J., Jänne, Pasi A., Costa, Daniel B., Varella-Garcia, Marileila, K

Journal:

Boston Medical and Surgical Journal

Année:

2010

Langue:

english

Fichier:

PDF, 1.11 MB

english, 2010

6

Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non-Small Cell Lung Cancer

Doebele, R. C., Pilling, A. B., Aisner, D. L., Kutateladze, T. G., Le, A. T., Weickhardt, A. J., Kondo, K. L., Linderman, D. J., Heasley, L. E., Franklin, W. A., Varella-Garcia, M., Camidge, D. R.

Journal:

Clinical Cancer Research

Année:

2012

Langue:

english

Fichier:

PDF, 1.22 MB

english, 2012

7

Self-poisoning in the UK: epidemiology and toxidromes

Camidge, R., Bateman, D. N.

Journal:

Clinical Medicine

Année:

2003

Langue:

english

Fichier:

PDF, 162 KB

english, 2003

8

Alectinib versus Crizotinib in Untreated ALK -Positive Non–Small-Cell Lung Cancer

Peters, Solange, Camidge, D. Ross, Shaw, Alice T., Gadgeel, Shirish, Ahn, Jin S., Kim, Dong-Wan, Ou, Sai-Hong I., Pérol, Maurice, Dziadziuszko, Rafal, Rosell, Rafael, Zeaiter, Ali, Mitry, Emmanuel, Go

Journal:

New England Journal of Medicine

Année:

2017

Langue:

english

Fichier:

PDF, 291 KB

english, 2017

9

Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Study

Camidge, D. Ross, Dziadziuszko, Rafal, Peters, Solange, Mok, Tony, Noe, Johannes, Nowicka, Malgorzata, Gadgeel, Shirish M., Cheema, Parneet, Pavlakis, Nick, de Marinis, Filippo, Cho, Byoung Chul, Zhan

Journal:

Journal of Thoracic Oncology

Année:

2019

Langue:

english

Fichier:

PDF, 506 KB

english, 2019

10

Manipulation of glycemic response with isomaltulose in a milk-based drink does not affect cognitive performance in healthy adults

Louise Dye, Mary B. Gilsenan, Frits Quadt, Vanessa E. G. Martens, Arjen Bot, Nicola Lasikiewicz, Diana Camidge, Fiona Croden, Clare Lawton

Journal:

Molecular Nutrition & Food Research

Année:

2010

Langue:

english

Fichier:

PDF, 222 KB

english, 2010

11

Characterizing the phenomenon of radiation recall dermatitis

Ross Camidge, Allan Price

Journal:

Radiotherapy and Oncology

Année:

2001

Langue:

english

Fichier:

PDF, 102 KB

english, 2001

12

G6 Clinical activity observed in a phase I dose escalation trial of an oral c-met and ALK inhibitor, PF-02341066

E.L. Kwak, D.R. Camidge, J. Clark, G.I. Shapiro, R.G. Maki, M.J. Ratain, B. Solomon, Y. Bang, S. Ou, R. Salgia

Journal:

European Journal of Cancer Supplements

Année:

2009

Langue:

english

Fichier:

PDF, 48 KB

english, 2009

13

Localized character of magnetotail magnetic fluctuations during polar magnetic substorms

Rostoker, Gordon, Camidge, F. Paul

Journal:

Journal of Geophysical Research

Année:

1971

Langue:

english

Fichier:

PDF, 467 KB

english, 1971

14

Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

von Pawel, Joachim, Harvey, Jimmie H., Spigel, David R., Dediu, Mircea, Reck, Martin, Cebotaru, Cristina L., Humphreys, Robin C., Gribbin, Matthew J., Fox, Norma Lynn, Camidge, D. Ross

Journal:

Clinical Lung Cancer

Année:

2014

Langue:

english

Fichier:

PDF, 569 KB

english, 2014

15

Acquired resistance to TKIs in solid tumours: learning from lung cancer

Camidge, D. Ross, Pao, William, Sequist, Lecia V.

Journal:

Nature Reviews Clinical Oncology (formerly Nature Clinical Practice Oncology)

Année:

2014

Langue:

english

Fichier:

PDF, 3.57 MB

english, 2014

16

Crizotinib in ROS1 -Rearranged Non–Small-Cell Lung Cancer

Shaw, Alice T., Ou, Sai-Hong I., Bang, Yung-Jue, Camidge, D. Ross, Solomon, Benjamin J., Salgia, Ravi, Riely, Gregory J., Varella-Garcia, Marileila, Shapiro, Geoffrey I., Costa, Daniel B., Doebele, Ro

Journal:

New England Journal of Medicine

Année:

2014

Langue:

english

Fichier:

PDF, 673 KB

english, 2014

17

Safety, Pharmacokinetic, and Pharmacodynamic Phase I Dose-Escalation Trial of PF-00562271, an Inhibitor of Focal Adhesion Kinase, in Advanced Solid Tumors

Infante, J. R., Camidge, D. R., Mileshkin, L. R., Chen, E. X., Hicks, R. J., Rischin, D., Fingert, H., Pierce, K. J., Xu, H., Roberts, W. G., Shreeve, S. M., Burris, H. A., Siu, L. L.

Journal:

Journal of Clinical Oncology

Année:

2012

Langue:

english

Fichier:

PDF, 153 KB

english, 2012

18

Response assessment criteria for brain metastases: proposal from the RANO group

Lin, Nancy U, Lee, Eudocia Q, Aoyama, Hidefumi, Barani, Igor J, Barboriak, Daniel P, Baumert, Brigitta G, Bendszus, Martin, Brown, Paul D, Camidge, D Ross, Chang, Susan M, Dancey, Janet, de Vries, Eli

Journal:

The Lancet Oncology

Année:

2015

Langue:

english

Fichier:

PDF, 1.60 MB

english, 2015

19

Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non-Small Cell Lung Cancer

Sang, J., Acquaviva, J., Friedland, J. C., Smith, D. L., Sequeira, M., Zhang, C., Jiang, Q., Xue, L., Lovly, C. M., Jimenez, J.-P., Shaw, A. T., Doebele, R. C., He, S., Bates, R. C., Camidge, D. R., M

Journal:

Cancer Discovery

Année:

2013

Langue:

english

Fichier:

PDF, 14.48 MB

english, 2013

20

BM-32 * CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL

Shaw, A., Mehra, R., Tan, D. S. W., Felip, E., Chow, L. Q. M., Ross Camidge, D., Vansteenkiste, J., Sharma, S., De Pas, T., Riely, G. J., Solomon, B. J., Wolf, J., Thomas, M., Schuler, M., Liu, G., Sa

Journal:

Année:

2014

Langue:

english

Fichier:

PDF, 31 KB

english, 2014

21

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

Gomez, Daniel R, Blumenschein, George R, Lee, J Jack, Hernandez, Mike, Ye, Rong, Camidge, D Ross, Doebele, Robert C, Skoulidis, Ferdinandos, Gaspar, Laurie E, Gibbons, Don L, Karam, Jose A, Kavanagh,

Journal:

The Lancet Oncology

Année:

2016

Langue:

english

Fichier:

PDF, 252 KB

english, 2016

22

Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer

Robin, Tyler P., Jones, Bernard L., Amini, Arya, Koshy, Matthew, Gaspar, Laurie E., Liu, Arthur K., Nath, Sameer K., Kavanagh, Brian D., Camidge, D. Ross, Rusthoven, Chad G.

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 298 KB

english, 2018

23

The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non–Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib

Patil, Tejas, Smith, Derek E., Bunn, Paul A., Aisner, Dara L., Le, Anh T., Hancock, Mark, Purcell, William T., Bowles, Daniel W., Camidge, D. Ross, Doebele, Robert C.

Journal:

Journal of Thoracic Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 981 KB

english, 2018

24

A Phase 1 Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors

Atrafi, Florence, Groen, Harry JM, Byers, Lauren Averett, Garralda, Elena, Lolkema, Martijn, Sangha, Randeep, Viteri, Santiago, Chae, Young Kwang, Camidge, D. Ross, Gabrail, Nashat, Hu, Beibei, Tian,

Journal:

Clinical Cancer Research

Année:

2018

Langue:

english

Fichier:

PDF, 1.67 MB

english, 2018

25

OA02.02 Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC

Lin, J., Kim, D., Drilon, A., Doebele, R., Lee, J., Zhu, V., Ahn, M., Lim, J., Stopatschinskaja, S., Cui, J.J., Hyman, D., Camidge, R., Ou, S., Shaw, A., Cho, B.C.

Journal:

Journal of Thoracic Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 124 KB

english, 2018

26

Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study

Solomon, Benjamin J, Besse, Benjamin, Bauer, Todd M, Felip, Enriqueta, Soo, Ross A, Camidge, D Ross, Chiari, Rita, Bearz, Alessandra, Lin, Chia-Chi, Gadgeel, Shirish M, Riely, Gregory J, Tan, Eng Huat

Journal:

The Lancet Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 1.30 MB

english, 2018

27

Predictive value of oncogenic driver subtype, programmed death‐1 ligand (PD‐L1) score, and smoking status on the efficacy of PD‐1/PD‐L1 inhibitors in patients with oncogene‐driven non–small cell lung cancer

Ng, Terry L., Liu, Yiwei, Dimou, Anastasios, Patil, Tejas, Aisner, Dara L., Dong, Zhengwei, Jiang, Tao, Su, Chunxia, Wu, Chunyan, Ren, Shengxiang, Zhou, Caicun, Camidge, D. Ross

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 846 KB

english, 2018

28

OA09 Preliminary Clinical Activity of Repotrectinib (TPX-0005) in Advanced ROS1 Fusion-Positive Non-Small Cell Lung Cancer

Ou, S., Cho, B.C., Kim, D., Drilon, A., Lee, J., Lin, J., Zhu, V., Ahn, M., Camidge, D.R., Stopatschinskaja, S. Shanna, Liu, J., Cui, J., Hyman, D., Doebele, R., Shaw, A.

Journal:

Journal of Thoracic Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 146 KB

english, 2018

29

Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer

Patil, Tejas, Pacheco, Jose M., Dimou, Anastasios, Purcell, William T., Rossi, Candice, Bunn, Paul A., Doebele, Robert C., Camidge, D. Ross, Ferrigno, Lisa

Journal:

Frontiers in Oncology

Année:

2020

Fichier:

PDF, 328 KB

2020

30

Patterns of Failure after First Line Systemic Therapy for Advanced NSCLC: Implications for Consolidative SBRT

K.E. Rusthoven, S.F. Hammerman, B.D. Kavanagh, M.J. Birtwhistle, M. Stares, D.R. Camidge

Journal:

International Journal of Radiation Oncology*Biology*Physics

Année:

2008

Langue:

english

Fichier:

PDF, 42 KB

english, 2008

31

Serum Cell Death Marker Increases after IMRT for Glioblastoma or SBRT for Epithelial Tumors: A Clinical Measure of Apoptosis as Therapeutic Mechanism

B. Kavanagh, C. Chen, A. Thorburn, L. Zhang, B. Frederick, D.R. Camidge

Journal:

International Journal of Radiation Oncology*Biology*Physics

Année:

2009

Langue:

english

Fichier:

PDF, 39 KB

english, 2009

32

A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) Combined with Erlotinib for Patients with Recurrent Non-small Cell Lung Cancer (NSCLC)

B. Kavanagh, R. Abdulrahman, D.R. Camidge, D.E. Gerber, P.A. Bunn, J. Schiller, H. Choy, L. Gaspar, R. Doebele, R.D. Timmerman

Journal:

International Journal of Radiation Oncology*Biology*Physics

Année:

2010

Langue:

english

Fichier:

PDF, 36 KB

english, 2010

33

Impact of Induction Chemotherapy on Estimated Risk of Radiation Pneumonitis in Small Cell (SCLC) and Non-small Cell Lung (NSCLC) Cancer

Amin, N., Miften, M., Kavanagh, B., Raben, D., Camidge, D., Thornton, D., Rochford, N., Gaspar, L.E.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Année:

2010

Langue:

english

Fichier:

PDF, 34 KB

english, 2010

34

Recommended dose antacids and severe hypercalcaemia

R. Camidge, R. Peaston

Journal:

British Journal of Clinical Pharmacology

Année:

2001

Langue:

english

Fichier:

PDF, 40 KB

english, 2001

35

The epidemiology of self-poisoning in the UK

D. R. Camidge, R. J. Wood, D. N. Bateman

Journal:

British Journal of Clinical Pharmacology

Année:

2003

Langue:

english

Fichier:

PDF, 103 KB

english, 2003

36

Factors determining the optimal body site and method for obtaining punch biopsies of human skin as a tissue in which to assess pharmacodynamic and pharmacokinetic endpoints in drug development studies

D. R. Camidge, M. J. Davies, P. J. Laud, A. L. Marshall, M. Cockerill, P. D. Smith, A. M. Hughes

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2006

Langue:

english

Fichier:

PDF, 248 KB

english, 2006

37

A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers

D. Ross Camidge, Dominic Smethurst, Jim Growcott, Nigel C. Barrass, John R. Foster, Salvatore Febbraro, Helen Swaisland, Andrew Hughes

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2007

Langue:

english

Fichier:

PDF, 324 KB

english, 2007

38

A phase I pharmacodynamic study of the effects of the cyclin-dependent kinase-inhibitor AZD5438 on cell cycle markers within the buccal mucosa, plucked scalp hairs and peripheral blood mononucleocytes of healthy male volunteers

D. Ross Camidge, Mike Pemberton, Jim Growcott, Dereck Amakye, David Wilson, Helen Swaisland, Cheryl Forder, Robert Wilkinson, Kate Byth, Andrew Hughes

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2007

Langue:

english

Fichier:

PDF, 390 KB

english, 2007

39

A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer

L. Q. M. Chow, N. Blais, D. J. Jonker, S. A. Laurie, S. G. Diab, C. Canil, M. McWilliam, A. Thall, A. Ruiz-Garcia, K. Zhang, L. Tye, R. C. Chao, D. R. Camidge

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2012

Langue:

english

Fichier:

PDF, 312 KB

english, 2012

40

A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancer

Qing Zhou, Daniel Gustafson, Sujatha Nallapareddy, Sami Diab, Stephen Leong, Karl Lewis, Lia Gore, Wells A. Messersmith, Anthony M. Treston, S. Gail Eckhardt, Carolyn Sidor, D. Ross Camidge

Journal:

Investigational New Drugs

Année:

2011

Langue:

english

Fichier:

PDF, 185 KB

english, 2011

41

The impact of prognosis without treatment on doctors' and patients' resource allocation decisions and its relevance to new drug recommendation processes

D. Ross Camidge, James J. Oliver, Carolyn Skinner, Ben Attwood, Fiona Nussey, Duncan Jodrell, David J. Webb

Journal:

British Journal of Clinical Pharmacology

Année:

2008

Langue:

english

Fichier:

PDF, 493 KB

english, 2008

42

Plucked human hair as a tissue in which to assess pharmacodynamic end points during drug development studies

Laud, P J, Smith, P D, Hughes, A M, Soames, A R, Camidge, D R, Randall, K R, Foster, J R, Sadler, C J, Wright, J A

Journal:

British Journal of Cancer

Année:

2005

Langue:

english

Fichier:

PDF, 205 KB

english, 2005

43

Assessing proliferation, cell-cycle arrest and apoptotic end points in human buccal punch biopsies for use as pharmacodynamic biomarkers in drug development

Camidge, D R, Pemberton, M N, Growcott, J W, Johnstone, D, Laud, P J, Foster, J R, Randall, K J, Hughes, A M

Journal:

British Journal of Cancer

Année:

2005

Langue:

english

Fichier:

PDF, 230 KB

english, 2005

44

Economic evaluation of fulvestrant as an extra step in the treatment sequence for ER-positive advanced breast cancer

Cameron, D A, Camidge, D R, Oyee, J, Hirsch, M

Journal:

British Journal of Cancer

Année:

2008

Langue:

english

Fichier:

PDF, 498 KB

english, 2008

45

Magnetic field perturbations in the magnetotail associated with polar magnetic substorms

Camidge, F. Paul, Rostoker, Gordon

Journal:

Canadian Journal of Physics

Année:

1970

Langue:

english

Fichier:

PDF, 422 KB

english, 1970

46

On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics

Dimberg, L Y, Anderson, C K, Camidge, R, Behbakht, K, Thorburn, A, Ford, H L

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 456 KB

english, 2012

47

Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer

Rudin, C. M., Hann, C. L., Garon, E. B., Ribeiro de Oliveira, M., Bonomi, P. D., Camidge, D. R., Chu, Q., Giaccone, G., Khaira, D., Ramalingam, S. S., Ranson, M. R., Dive, C., McKeegan, E. M., Chyla,

Journal:

Clinical Cancer Research

Année:

2012

Langue:

english

Fichier:

PDF, 314 KB

english, 2012

48

Correlations between the percentage of tumor cells showing an anaplastic lymphoma kinase (ALK) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization–positive nonsmall cell lung cancer

D. Ross Camidge, Mariana Theodoro, DeLee A. Maxson, Margaret Skokan, Tara O'Brien, Xian Lu, Robert C. Doebele, Anna E. Barón, Marileila Varella-Garcia

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 515 KB

english, 2012

49

Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer

Andrew J. Weickhardt, Micol S. Rothman, Smita Salian-Mehta, Katja Kiseljak-Vassiliades, Ana B. Oton, Robert C. Doebele, Margaret E. Wierman, D. Ross Camidge

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 452 KB

english, 2012

50

A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumors

Leong, S., Eckhardt, S. G., Chan, E., Messersmith, W. A., Spratlin, J., Camidge, D. R., Diab, S., Khosravan, R., Lin, X., Chow Maneval, E., Lockhart, A. C.

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2012

Langue:

english

Fichier:

PDF, 244 KB

english, 2012